2.1 Live birth |
5 |
1295 |
Risk Ratio (M‐H, Random, 95% CI) |
1.27 [1.09, 1.49] |
2.1.1 UFH + aspirin versus aspirin |
2 |
140 |
Risk Ratio (M‐H, Random, 95% CI) |
1.74 [1.28, 2.35] |
2.1.2 LMWH + aspirin versus aspirin |
3 |
1155 |
Risk Ratio (M‐H, Random, 95% CI) |
1.20 [1.04, 1.38] |
2.2 Pre‐eclampsia |
2 |
82 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.57 [0.10, 3.14] |
2.3 Adverse events in the mother |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
2.3.1 Bleeding |
1 |
31 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.65 [0.19, 14.03] |
2.3.2 Heparin‐induced thrombocytopenia |
2 |
140 |
Risk Ratio (M‐H, Fixed, 95% CI) |
Not estimable |
2.3.3 Allergic reactions |
1 |
90 |
Risk Ratio (M‐H, Fixed, 95% CI) |
Not estimable |
2.4 Venous thromboembolism |
3 |
182 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
2.5 Arterial thromboembolism |
3 |
182 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
2.6 Preterm delivery of a live infant |
3 |
156 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.93 [0.42, 2.07] |
2.7 Intrauterine growth restriction |
3 |
151 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.85 [0.33, 2.19] |
2.8 Adverse events in the child |
1 |
51 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
2.8.1 Congenital malformations |
1 |
51 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
2.9 Pregnancy loss |
5 |
1295 |
Risk Ratio (M‐H, Random, 95% CI) |
0.48 [0.32, 0.71] |
2.9.1 UFH + aspirin versus aspirin |
2 |
140 |
Risk Ratio (M‐H, Random, 95% CI) |
0.46 [0.29, 0.71] |
2.9.2 LMWH + aspirin versus aspirin |
3 |
1155 |
Risk Ratio (M‐H, Random, 95% CI) |
0.55 [0.26, 1.16] |